Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium plus bisphosphonates vs bisphosphonates alone in postmenopausal osteoporosis
2021-005401-28Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Dec 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of magnesium in postmenopausal osteoporosis (2 arms), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Change in CTX-I after one year. Started Dec 2021; status: completed.
02
Drugs
magnesium
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on 2021-005401-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-005401-28.